$3.280
-0.333 (-10.14%)收盤時
- 最高
- 3.840
- 開盤
- 3.600
- 成交量加權均價
- 3.40
- 成交量
- 61.95K
- 市值
- —
- 最低
- 3.090
- 成交金額
- 210.82K
- 企業價值/稅息折舊攤銷前利潤(TTM)
- 0.00
Organic Plant Health, Inc. produces, distributes, and sells organic based fertilizers and soil conditioners for the care and maintenance of residential and commercial lawns, gardens, and farms. The company's products include granular and liquid fertilizers, soil conditioners, and pest control products. It sells its products through retail partners in the North Carolina region. The company also operates a retail location in Matthews, North Carolina. It serves residential customers and commercial landscapers. Organic Plant Health, Inc. was incorporated in 2007 and is headquartered in Scottsdale, Arizona.
AI 分析 of Organic Plant Health Inc (OPHI)
買進Sophia Genetics (SOPH) is a good buy right now due to its current price of $8.21, which is significantly below the analyst price targets of $9 to $14. The company has shown a remarkable year-to-date change of +75.80% and a 52-week high of $8.98, indicating strong upward momentum. Additionally, the RSI is at 68.74, suggesting the stock is nearing overbought territory but still has room for growth. The main risk is the negative earnings per share of -0.30 reported in Q2 2026, which indicates ongoing losses, but the company's revenue growth of 27% year-over-year and partnerships with AstraZeneca provide a solid growth outlook.
估值指標
OPHI 常見問題 —— 由 Alphio AI 解答
Organic Plant Health, Inc. produces, distributes, and sells organic based fertilizers and soil conditioners for the care and maintenance of residential and commercial lawns, gardens, and farms. The company's products include granular and liquid fertilizers, soil conditioners, and pest control products. It sells its products through retail partners in the North Carolina region. The company also operates a retail location in Matthews, North Carolina. It serves residential customers and commercial landscapers. Organic Plant Health, Inc. was incorporated in 2007 and is headquartered in Scottsdale, Arizona. It operates in the Basic Materials sector.
Sophia Genetics (SOPH) is a good buy right now due to its current price of $8.21, which is significantly below the analyst price targets of $9 to $14. The company has shown a remarkable year-to-date change of +75.80% and a 52-week high of $8.98, indicating strong upward momentum. Additionally, the RSI is at 68.74, suggesting the stock is nearing overbought territory but still has room for growth. The main risk is the negative earnings per share of -0.30 reported in Q2 2026, which indicates ongoing losses, but the company's revenue growth of 27% year-over-year and partnerships with AstraZeneca provide a solid growth outlook.
社群
更多 ↗暫無貼文
註冊或登入後參與討論相關文章
- How to Invest in IPOs: What SpaceX, Cerebras and the Anthropic Debut Teach Investors in 2026How to invest in IPOs as Anthropic lists: how retail allocations work, what IPO data show about returns, SpaceX and Cerebras lessons, lockups and index rules.
- Is the Stock Market Overvalued? Why CAPE Says Yes and the Forward P/E Says Not So FastIs the stock market overvalued? The CAPE is near 39 but the forward P/E is 17.7. What each measure says, the bond yield test, and how to invest in late 2026.
- High Yield Bonds in 2026: What CCC Credit Stress Means for Income Investors and StocksHigh yield bonds pay about 8% in 2026, but CCC spreads have blown out. Learn what credit spreads signal for stocks and how to invest in junk bonds wisely.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。